4
Changes in Ownership
Travere Therapeutics, Inc. Filed Acc 0001415889-25-010643
CHIEF FINANCIAL OFFICER sold 48 shares at $13.14 ($631)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cline Christopher R. CHIEF FINANCIAL OFFICER | 2025-04-11 | Sale | −48 | $13.14 | $631 | 89,990 | D |
| Open-market sales · 48 sh · avg $13.14 · $631 | |||||||
Loading xslF345X05/form4-04142025_100426.xml…